Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Australia Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20132
20141
20155
20163
20179
20184
20194
20206
20215
20226
20235
20247
202513
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting31
Terminated18
Completed14
Active, not recruiting13
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb7
Pfizer7
AstraZeneca4
BioNTech SE4
Eli Lilly and Company4
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Amgen2
Dizal Pharmaceuticals2
DualityBio Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung78
Colorectal Neoplasms20
Melanoma20
Stomach Neoplasms16
Squamous Cell Carcinoma of Head and Neck15
Lung Neoplasms14
Neoplasm Metastasis14
Breast Neoplasms12
Neoplasms10
Carcinoma, Renal Cell9

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.